DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
PHOSPHATIDYLCHOLINE
3
Small molecule
Investigational
Unknown
Unknown
Schizophrenia; Colitis, Ulcerative; Wounds and Injuries; Hepatitis, Autoimmune
Unknown
PHOSPHATIDYLCHOLINE
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C40H80NO8PS2
Molecular Weight:
798.19
AlogP:
10.52
PSA:
111.19
HBD:
0.0
HBA:
#RotB:
40.0
Source:
VELIMOGENE ALIPLASMID
3
Gene
Investigational
Unknown
Unknown
Melanoma
Unknown
VELIMOGENE ALIPLASMID
×
Maximum Phase:
3
First Approval:
None
UNII:
XIH6R5Y286
Molecule Type:
Gene
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ORNIDAZOLE
3
Small molecule
Investigational
Unknown
Unknown
Colonic Neoplasms; Rectal Neoplasms; Bacterial Infections
Unknown
ORNIDAZOLE
×
Maximum Phase:
3
First Approval:
None
UNII:
62XCK0G93T
Molecule Type:
Small molecule
Molecular Formula:
C7H10ClN3O3
Molecular Weight:
219.63
AlogP:
0.7
PSA:
81.19
HBD:
1.0
HBA:
#RotB:
4.0
Source:
POLOXAMER
3
Small molecule
Investigational
Unknown
Unknown
Anemia, Sickle Cell; Neuralgia
Unknown
POLOXAMER
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MELPERONE
3
Small molecule
Investigational
Unknown
Unknown
Anxiety; Dementia; Depressive Disorder; Psychotic Disorders; Schizophrenia
Unknown
MELPERONE
×
Maximum Phase:
3
First Approval:
None
UNII:
J8WA3K39B7
Molecule Type:
Small molecule
Molecular Formula:
C16H22FNO
Molecular Weight:
263.36
AlogP:
3.52
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
5.0
Source:
ECHINACEA, UNSPECIFIED
3
Unknown
Investigational
Unknown
Unknown
Common Cold; Pharyngitis
Unknown
ECHINACEA, UNSPECIFIED
×
Maximum Phase:
3
First Approval:
None
UNII:
4N9P6CC1DX
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PARDOPRUNOX
3
Small molecule
Investigational
Unknown
Unknown
Parkinson Disease
Dopamine receptors; D2 & D3 partial agonist
PARDOPRUNOX
×
Maximum Phase:
3
First Approval:
None
UNII:
5R72CHP32S
Molecule Type:
Small molecule
Molecular Formula:
C12H15N3O2
Molecular Weight:
233.27
AlogP:
0.87
PSA:
52.48
HBD:
1.0
HBA:
#RotB:
1.0
Source:
BAN2401
3
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
BAN2401
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LECOZOTAN HYDROCHLORIDE
3
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Serotonin 1a (5-HT1a) receptor antagonist
LECOZOTAN HYDROCHLORIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
23EDE20K1X
Molecule Type:
Small molecule
Molecular Formula:
C28H30ClN5O3
Molecular Weight:
520.03
AlogP:
3.58
PSA:
81.93
HBD:
0.0
HBA:
#RotB:
6.0
Source:
VEVERIMER
3
Small molecule
Investigational
Unknown
Unknown
Acidosis
Hydrochloric acid sequestering agent
VEVERIMER
×
Maximum Phase:
3
First Approval:
None
UNII:
10VSMQY402
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HC-1119
3
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
HC-1119
×
Maximum Phase:
3
First Approval:
None
UNII:
3OKI556HC2
Molecule Type:
Small molecule
Molecular Formula:
C21H16F4N4O2S
Molecular Weight:
467.46
AlogP:
3.99
PSA:
76.44
HBD:
1.0
HBA:
#RotB:
3.0
Source:
FELADILIMAB
3
Antibody
Investigational
Unknown
Unknown
Multiple Myeloma; Neoplasms; Head and Neck Neoplasms
Inducible T-cell costimulator agonist
FELADILIMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MINRETUMOMAB
3
Antibody
Investigational
Unknown
Unknown
Colonic Neoplasms; Colorectal Neoplasms; Esophageal Neoplasms; Pancreatic Neoplasms; Rectal Neoplasms; Stomach Neoplasms
Tumor-associated antigen 72 binding agent
MINRETUMOMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
235435CH6L
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PEGINTERFERON LAMBDA-1A
3
Protein
Investigational
Unknown
Unknown
Hepatitis B, Chronic; Hepatitis D; Hepatitis C; Hepatitis C, Chronic; Severe Acute Respiratory Syndrome
Interferon lambda receptor agonist
PEGINTERFERON LAMBDA-1A
×
Maximum Phase:
3
First Approval:
None
UNII:
0T0250N43U
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRYPSIN, CRYSTALLIZED
3
Unknown
Investigational
Unknown
Unknown
Skin Ulcer
Unknown
TRYPSIN, CRYSTALLIZED
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
POWDERED CELLULOSE
3
Unknown
Investigational
Unknown
Unknown
Peripheral Arterial Disease; Schizophrenia; Osteoarthritis
Unknown
POWDERED CELLULOSE
×
Maximum Phase:
3
First Approval:
None
UNII:
SMD1X3XO9M
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPRODISATE
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EPRODISATE
×
Maximum Phase:
3
First Approval:
None
UNII:
6QFP76V7S7
Molecule Type:
Small molecule
Molecular Formula:
C3H8O6S2
Molecular Weight:
204.22
AlogP:
-0.85
PSA:
108.74
HBD:
2.0
HBA:
#RotB:
4.0
Source:
OMFILOCTOCOG ALFA
3
Unknown
Investigational
Unknown
Unknown
Hemophilia A
Unknown
OMFILOCTOCOG ALFA
×
Maximum Phase:
3
First Approval:
None
UNII:
74D9ZOJ6IR
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEVOKETOCONAZOLE
3
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Cushing Syndrome; Pituitary ACTH Hypersecretion
Unknown
LEVOKETOCONAZOLE
×
Maximum Phase:
3
First Approval:
None
UNII:
R9400W927I
Molecule Type:
Small molecule
Molecular Formula:
C26H28Cl2N4O4
Molecular Weight:
531.44
AlogP:
4.21
PSA:
69.06
HBD:
0.0
HBA:
#RotB:
7.0
Source:
TARANABANT
3
Small molecule
Investigational
Unknown
Unknown
Tobacco Use Disorder; Urinary Incontinence; Diabetes Mellitus, Type 2; Obesity
Cannabinoid CB1 receptor inverse agonist
TARANABANT
×
Maximum Phase:
3
First Approval:
None
UNII:
X9U622S114
Molecule Type:
Small molecule
Molecular Formula:
C27H25ClF3N3O2
Molecular Weight:
515.96
AlogP:
6.31
PSA:
75.01
HBD:
1.0
HBA:
#RotB:
8.0
Source:
DOMVANALIMAB
3
Antibody
Investigational
Unknown
Unknown
Glioblastoma; Neoplasms; Carcinoma, Non-Small-Cell Lung
T-cell immunoreceptor with Ig and ITIM domains inhibitor
DOMVANALIMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SESAME OIL
3
Small molecule
Investigational
Unknown
Unknown
Lichen Planus, Oral; Breast Neoplasms; Hematologic Neoplasms
Unknown
SESAME OIL
×
Maximum Phase:
3
First Approval:
None
UNII:
QX10HYY4QV
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEXTRAN
3
Small molecule
Investigational
Unknown
Unknown
HIV Infections; Hyperopia; Keratoconus; Refractive Errors; Brain Injuries
Unknown
DEXTRAN
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C18H32O16
Molecular Weight:
504.44
AlogP:
-7.73
PSA:
276.52
HBD:
11.0
HBA:
#RotB:
11.0
Source:
BGB-290
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BGB-290
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BIIB067
3
Oligonucleotide
Investigational
Unknown
Unknown
Unknown
Unknown
BIIB067
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CUSTIRSEN
3
Oligonucleotide
Investigational
Unknown
Unknown
Neoplasms; Carcinoma, Non-Small-Cell Lung; Prostatic Neoplasms, Castration-Resistant
Clusterin mRNA antisense inhibitor
CUSTIRSEN
×
Maximum Phase:
3
First Approval:
None
UNII:
L26E95NLRK
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VERUBECESTAT
3
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Beta-secretase 1 inhibitor
VERUBECESTAT
×
Maximum Phase:
3
First Approval:
None
UNII:
J1I0P6WT7T
Molecule Type:
Small molecule
Molecular Formula:
C17H17F2N5O3S
Molecular Weight:
409.42
AlogP:
1.63
PSA:
115.25
HBD:
3.0
HBA:
#RotB:
3.0
Source:
RELTECIMOD
3
Protein
Investigational
Unknown
Unknown
Infections
Unknown
RELTECIMOD
×
Maximum Phase:
3
First Approval:
None
UNII:
U00J02UY29
Molecule Type:
Protein
Molecular Formula:
C46H72N10O15S
Molecular Weight:
1037.2
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
RUBIDIUM RB-82
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Diagnostic agent
RUBIDIUM RB-82
×
Maximum Phase:
3
First Approval:
None
UNII:
9K730EL8KU
Molecule Type:
Small molecule
Molecular Formula:
Rb
Molecular Weight:
81.92
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PEGUNIGALSIDASE ALFA
3
Enzyme
Investigational
Unknown
Unknown
Fabry Disease
Globotriosylceramide hydrolytic enzyme
PEGUNIGALSIDASE ALFA
×
Maximum Phase:
3
First Approval:
None
UNII:
8M7V7Q6537
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GUANINE
3
Small molecule
Investigational
Unknown
Unknown
Glioblastoma; Gliosarcoma; Lymphoma; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Sezary Syndrome; Astrocytoma; Central Nervous System Neoplasms; Colorectal Neoplasms; Melanoma; Multiple Myeloma; Oligodendroglioma; Sarcoma; Neoplasms
Unknown
GUANINE
×
Maximum Phase:
3
First Approval:
None
UNII:
5Z93L87A1R
Molecule Type:
Small molecule
Molecular Formula:
C5H5N5O
Molecular Weight:
151.13
AlogP:
-0.77
PSA:
100.45
HBD:
3.0
HBA:
#RotB:
0.0
Source:
TEREVALEFIM
3
Small molecule
Investigational
Unknown
Unknown
Acute Kidney Injury
Hepatocyte growth factor receptor agonist
TEREVALEFIM
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C9H8N2S
Molecular Weight:
176.24
AlogP:
2.64
PSA:
28.68
HBD:
1.0
HBA:
#RotB:
2.0
Source:
FASIGLIFAM
3
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus; Diabetes Mellitus, Type 2
Free fatty acid receptor 1 positive allosteric modulator
FASIGLIFAM
×
Maximum Phase:
3
First Approval:
None
UNII:
GLP1W4JXAH
Molecule Type:
Small molecule
Molecular Formula:
C29H32O7S
Molecular Weight:
524.64
AlogP:
5.31
PSA:
99.13
HBD:
1.0
HBA:
#RotB:
11.0
Source:
SUTIMLIMAB
3
Antibody
Investigational
Unknown
Unknown
Purpura, Thrombocytopenic, Idiopathic
Complement C1s inhibitor
SUTIMLIMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
GNWE7KJ995
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEUCINE
3
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder; Hyperoxaluria, Primary; Neoplasms; Sarcopenia; Depressive Disorder, Major; Diabetes Mellitus, Type 2; Red-Cell Aplasia, Pure
Unknown
LEUCINE
×
Maximum Phase:
3
First Approval:
None
UNII:
GMW67QNF9C
Molecule Type:
Small molecule
Molecular Formula:
C6H13NO2
Molecular Weight:
131.18
AlogP:
0.44
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
3.0
Source:
1
2
…
240
241
242
243
244
245
246
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA